Gastrointestinal Manifestations Among Patients With COVID19

many patients with confirmed infection with COVID-19 suffer from different symptoms and signs of gastrointestinal symptoms

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Ahmed

Al Minyā, Alminya, 71515, Egypt

About this study

many patients with COVID1-9 infection experienced many intestinal symptoms mainly abdominal pain, vomiting, and diarrhea. This study aimed to assess the frequency of GIT manifestations among patients with COVID-19 and its impact on the outcome

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

all patients with COVID19

Exclusion criteria

patient refusal to participate in the study

Treatment and study plan

Primary outcomes

frequency of GIT symptoms among patients with COVID-19 infection

Time frame: Baseline

any GIT symptoms in such patients were recorded

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Gastrointestinal Manifestations in COVID-19: Symptoms and Signs and Its Impact on the Outcome

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: Sep 10, 2020
Registry last updated: Sep 10, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed